Lorena Alba‐Castellón

980 total citations
30 papers, 703 citations indexed

About

Lorena Alba‐Castellón is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lorena Alba‐Castellón has authored 30 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Oncology and 13 papers in Immunology. Recurrent topics in Lorena Alba‐Castellón's work include Immunotherapy and Immune Responses (9 papers), Cancer Cells and Metastasis (6 papers) and Cancer Research and Treatments (5 papers). Lorena Alba‐Castellón is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Cancer Cells and Metastasis (6 papers) and Cancer Research and Treatments (5 papers). Lorena Alba‐Castellón collaborates with scholars based in Spain, Argentina and United Kingdom. Lorena Alba‐Castellón's co-authors include Antonio Garcı́a de Herreros, Esther Vázquez, Ramón Mangues, Antonio Villaverde, Ugutz Unzueta, Isolda Casanova, Patricia Álamo, Mireia Duñach, Naroa Serna and Alberto Gallardo and has published in prestigious journals such as Molecular Cell, PLoS ONE and Biomaterials.

In The Last Decade

Lorena Alba‐Castellón

28 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorena Alba‐Castellón Spain 16 426 245 181 90 67 30 703
David Pépin United States 19 494 1.2× 204 0.8× 167 0.9× 111 1.2× 51 0.8× 51 1.1k
Manami Shimomura Japan 15 328 0.8× 360 1.5× 345 1.9× 76 0.8× 60 0.9× 35 763
Lin Meng China 20 517 1.2× 380 1.6× 209 1.2× 180 2.0× 38 0.6× 40 979
Valerie R. Wiersma Netherlands 18 431 1.0× 252 1.0× 564 3.1× 84 0.9× 95 1.4× 35 971
Mike Maillasson France 17 316 0.7× 215 0.9× 271 1.5× 58 0.6× 43 0.6× 31 761
Annamari Heiskanen Finland 13 577 1.4× 174 0.7× 141 0.8× 54 0.6× 87 1.3× 25 861
Ning Deng China 12 468 1.1× 276 1.1× 93 0.5× 186 2.1× 41 0.6× 22 723
Heungnam Kim United States 10 274 0.6× 152 0.6× 128 0.7× 61 0.7× 106 1.6× 11 574
Yen Phung United States 14 278 0.7× 258 1.1× 169 0.9× 75 0.8× 93 1.4× 15 966
Silvia Mele United Kingdom 13 257 0.6× 300 1.2× 208 1.1× 51 0.6× 78 1.2× 23 681

Countries citing papers authored by Lorena Alba‐Castellón

Since Specialization
Citations

This map shows the geographic impact of Lorena Alba‐Castellón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorena Alba‐Castellón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorena Alba‐Castellón more than expected).

Fields of papers citing papers by Lorena Alba‐Castellón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorena Alba‐Castellón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorena Alba‐Castellón. The network helps show where Lorena Alba‐Castellón may publish in the future.

Co-authorship network of co-authors of Lorena Alba‐Castellón

This figure shows the co-authorship network connecting the top 25 collaborators of Lorena Alba‐Castellón. A scholar is included among the top collaborators of Lorena Alba‐Castellón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorena Alba‐Castellón. Lorena Alba‐Castellón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gallardo, Alberto, Eric Voltà‐Durán, A.C. Virgili Manrique, et al.. (2025). A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation. International Journal of Nanomedicine. Volume 20. 2445–2460. 3 indexed citations
2.
Manrique, A.C. Virgili, Juliana Salazar, Alberto Gallardo, et al.. (2024). CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics. 14(11). 1195–1195.
3.
López‐Laguna, Hèctor, Eric Voltà‐Durán, Lorena Alba‐Castellón, et al.. (2024). Lyophilization of biomimetic amyloids preserves their regulatable, endocrine-like functions for nanoparticle release. Applied Materials Today. 39. 102348–102348. 7 indexed citations
4.
Voltà‐Durán, Eric, Lorena Alba‐Castellón, Naroa Serna, et al.. (2023). High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles. Acta Biomaterialia. 170. 543–555. 4 indexed citations
5.
Alba‐Castellón, Lorena, Eloi Parladé, Eric Voltà‐Durán, et al.. (2023). Site-directed cysteine coupling of disulfide-containing non-antibody carrier proteins (THIOCAPs). Science China Materials. 66(10). 4109–4120. 1 indexed citations
6.
Gallardo, Alberto, Irene Arroyo‐Solera, Patricia Álamo, et al.. (2022). A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model. Pharmaceutics. 14(4). 887–887. 9 indexed citations
7.
Falgàs, Aïda, Naroa Serna, Laura Sánchez‐García, et al.. (2022). A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4+ lymphoma cells without toxicity in immunocompromised and immunocompetent mice. Biomedicine & Pharmacotherapy. 150. 112940–112940. 8 indexed citations
8.
Serna, Naroa, Víctor Pallarès, Ugutz Unzueta, et al.. (2022). Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery. Journal of Controlled Release. 343. 277–287. 11 indexed citations
9.
Arroyo‐Solera, Irene, Patricia Álamo, Isolda Casanova, et al.. (2022). CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 41(1). 49–49. 38 indexed citations
10.
Álamo, Patricia, Juan Cedano, Oscar Conchillo‐Solé, et al.. (2021). Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines. Acta Biomaterialia. 130. 211–222. 13 indexed citations
11.
Pallarès, Víctor, Ugutz Unzueta, Aïda Falgàs, et al.. (2021). A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model. Biomaterials. 280. 121258–121258. 21 indexed citations
12.
Arroyo‐Solera, Irene, Patricia Álamo, Isolda Casanova, et al.. (2021). Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4+ head and neck squamous cell carcinoma tumors. Acta Pharmaceutica Sinica B. 12(5). 2578–2591. 26 indexed citations
13.
Falgàs, Aïda, Víctor Pallarès, Ugutz Unzueta, et al.. (2021). Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4+ Diffuse Large B-Cell Lymphoma Cells. International Journal of Nanomedicine. Volume 16. 1869–1888. 20 indexed citations
14.
Peña, Raúl, José Rodríguez-Morató, Lorena Alba‐Castellón, et al.. (2020). Glutamine-Directed Migration of Cancer-Activated Fibroblasts Facilitates Epithelial Tumor Invasion. Cancer Research. 81(2). 438–451. 52 indexed citations
15.
Pallarès, Víctor, Ugutz Unzueta, Aïda Falgàs, et al.. (2020). An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination. Journal of Hematology & Oncology. 13(1). 36–36. 51 indexed citations
16.
Falgàs, Aïda, Víctor Pallarès, Naroa Serna, et al.. (2020). Selective delivery of T22-PE24-H6 to CXCR4+ diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model. Theranostics. 10(12). 5169–5180. 26 indexed citations
17.
Sánchez‐García, Laura, Rita Sala, Naroa Serna, et al.. (2020). A refined cocktailing of pro-apoptotic nanoparticles boosts anti-tumor activity. Acta Biomaterialia. 113. 584–596. 17 indexed citations
18.
Alba‐Castellón, Lorena, Raúl Peña, Mercedes Herrera, et al.. (2016). Snail1-Dependent Activation of Cancer-Associated Fibroblast Controls Epithelial Tumor Cell Invasion and Metastasis. Cancer Research. 76(21). 6205–6217. 69 indexed citations
19.
Alba‐Castellón, Lorena, Raquel Batlle, Clara Francı́, et al.. (2014). Snail1 Expression Is Required for Sarcomagenesis. Neoplasia. 16(5). 413–421. 24 indexed citations
20.
Sanchís, Ana, Lorena Alba‐Castellón, Víctor Latorre, Lisa M. Sevilla, & Paloma Pérez. (2012). Keratinocyte-Targeted Overexpression of the Glucocorticoid Receptor Delays Cutaneous Wound Healing. PLoS ONE. 7(1). e29701–e29701. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Pépin Breakdown of academic impact, for papers by Manami Shimomura Breakdown of academic impact, for papers by Lin Meng Breakdown of academic impact, for papers by Valerie R. Wiersma Breakdown of academic impact, for papers by Mike Maillasson Breakdown of academic impact, for papers by Annamari Heiskanen Breakdown of academic impact, for papers by Ning Deng Breakdown of academic impact, for papers by Heungnam Kim Breakdown of academic impact, for papers by Yen Phung Breakdown of academic impact, for papers by Silvia Mele
Rankless by CCL
2026